High Tower Advisors, LLC Aspira Women'S Health Inc. Transaction History

High Tower Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$0.88 - $1.81 $572 - $1,176	-650 Reduced 3.15%	20,000 $21,000
Q4 2021 Feb 10, 2022	BUY	$1.63 - $3.43 $1,059 - $2,229	650 Added 3.25%	20,650 $36,000
Q3 2021 Nov 12, 2021	SELL	$3.19 - $5.48 $8,613 - $14,796	-2,700 Reduced 11.89%	20,000 $65,000
Q1 2021 May 10, 2021	BUY	$5.9 - $9.13 $3,540 - $5,478	600 Added 2.71%	22,700 $153,000
Q4 2020 Feb 10, 2021	BUY	$3.0 - $6.71 $6,300 - $14,091	2,100 Added 10.5%	22,100 $148,000
Q2 2020 Aug 10, 2020	BUY	$0.78 - $5.25 $15,600 - $105,000	20,000 New	20,000 $77,000

431K

Ticker AWH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 124,296,000
Market Cap $123M
Description
Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gyneco...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.